Corrigendum to: Cytoprotective and cytotoxic effects of rice bran extracts in rat H9c2(2-1) cardiomyocytes (Oxidative Medicine and Cellular Longevity (2016) 2016 (6943053) DOI: 10.1155/2016/6943053)

In the article titled "Cytoprotective and Cytotoxic Effects of Rice Bran Extracts in Rat H9c2(2-1) Cardiomyocytes" [1], errors in statistical analyses for inhibitory concentration (IC₅₀) have resulted in incorrect tabulations of data for both Tables 2 and 4. The corrected versions of both tables are as below. Accordingly, in the "Results" (Section 3.1), the text reading "Based on the results (Table 2), the IC₅₀ values of RBE of BJLN were in the range of 61.67 to 64.57 μg/mL over 24, 48, and 72 hours of incubation time." should be corrected to "Based on the results (Table 2), the IC₅₀ values of RBE of BJLN were in the range of 59.57 to 64.27 μg/mL over 24, 48, and 72 hours of incubation time.", and "Based on the results, the IC₅₀ values of MR219 RBE were in the range of 95.44 to 111.50 μg/mL over the three different incubation periods (Table 2)." should be corrected to "Based on the results, the IC₅₀ values of MR219 RBE were in the range of 95.56 to 111.40 μg/mL over the three different incubation periods (Table 2)." In addition, in the "Results" (Section 3.3), the text reading "The positive effects were more distinctive with lower concentrations of RBE (BJLN: 25 μg/mL; MR219: 50 μg/mL) with observable increments in IC₅₀ of H₂O₂ (BJLN: 645.65 μM; MR219: 320.63 μM) (Table 4) when compared to negative control (316.23 μM). When the two extracts were compared, BJLN (25 μg/mL) extract outran MR219 (50 μg/mL) extract in terms of efficacy with a significant increment in IC₅₀ of H₂O₂ approximately twofold (645.65 μM) versus 1.4% (in approximation) when compared to negative control (316.23 μM)." should be replaced with "The positive effects were more distinctive with lower concentrations of RBE (BJLN: 25 μg/mL; MR219: 50 μg/mL) with observable increments in IC₅₀ of H₂O₂ (BJLN: 597.20 μM; MR219: 364.20 μM) (Table 4) when compared to negative control (271.00 μM). When the two extracts were compared, BJLN (25 μg/mL) extract outran MR219 (50 μg/mL) extract in terms of efficacy with a significant increment in IC₅₀ of H₂O₂ by approximately 2-fold (597.20 μM) versus 1.4-fold (in approximation) when compared to negative control (271.00 μM).", and the text reading "Significant decrements in the IC₅₀ values of H₂O₂ were found for cell pretreated with 50 μg/mL BJLN (92.90 μM) and 100 μg/mL MR219 (171.79 μM) extracts when compared to negative control (316.23 μM) (Table 4). The higher concentrations of BJLN and MR219 extracts selected were near the range of IC₅₀ of both extracts (IC₅₀ of BJLN: 52.18 μg/mL to 73.09 μg/mL; IC₅₀ of MR219: 95.44 μg/mL to 111.50 μg/mL)." should be replaced with "Significant decrements in the IC₅₀ values of H₂O₂ were found for cell pretreated with 50 μg/mL BJLN (89.95 μM) and 100 μg/mL MR219 (143.90 μM) extracts when compared to negative control (271.00 μM) (Table 4). The higher concentrations of BJLN and MR219 extracts selected were near the range of IC₅₀ of both extracts (IC₅₀ of BJLN: 59.57 μg/mL to 64.27 μg/mL; IC₅₀ of MR219: 95.56 μg/mL to 111.40 μg/mL)." An incorrect version of Figure 3 with missing graphical elements was published. The corrected version of Figure 3 with the inclusion of graphical elements is as shown below. Accordingly, Figure 5(b) presented in the original manuscript was also the incorrect version. The fourth datum point for MR219 (50 μg/mL) (grey dotted line) was incorrectly plotted. The correct version of the figure is as shown below with the corrected fourth datum point for MR219 (50 μg/mL) (grey dotted line). (Figure Presented).